IPO Boutique

Minerva Neurosciences IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Minerva Neurosciences, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Minerva NeurosciencesNERV -
NASDAQ
$10.00-$12.00 $6.00 $6.005.5 million7/1/2014
Jefferies
Co-Manager(s):
Baird, JMP Securities
Health Care
Filing(s):

Filed 2014-04-10
Terms Added 2014-06-10



Minerva Neurosciences Quote & Chart - Click for current quote - NERV

About Minerva Neurosciences (adapted from Minerva Neurosciences prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "NERV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved